Suppr超能文献

造血转录因子PU.1与GATA-1的直接相互作用:在红细胞中的功能拮抗作用

Direct interaction of hematopoietic transcription factors PU.1 and GATA-1: functional antagonism in erythroid cells.

作者信息

Rekhtman N, Radparvar F, Evans T, Skoultchi A I

机构信息

Department of Cell Biology, Albert Einstein College of Medicine, Bronx, New York 10461, USA.

出版信息

Genes Dev. 1999 Jun 1;13(11):1398-411. doi: 10.1101/gad.13.11.1398.

Abstract

Malignant transformation usually inhibits terminal cell differentiation but the precise mechanisms involved are not understood. PU.1 is a hematopoietic-specific Ets family transcription factor that is required for development of some lymphoid and myeloid lineages. PU.1 can also act as an oncoprotein as activation of its expression in erythroid precursors by proviral insertion or transgenesis causes erythroleukemias in mice. Restoration of terminal differentiation in the mouse erythroleukemia (MEL) cells requires a decline in the level of PU.1, indicating that PU.1 can block erythroid differentiation. Here we investigate the mechanism by which PU.1 interferes with erythroid differentiation. We find that PU.1 interacts directly with GATA-1, a zinc finger transcription factor required for erythroid differentiation. Interaction between PU.1 and GATA-1 requires intact DNA-binding domains in both proteins. PU.1 represses GATA-1-mediated transcriptional activation. Both the DNA binding and transactivation domains of PU.1 are required for repression and both domains are also needed to block terminal differentiation in MEL cells. We also show that ectopic expression of PU.1 in Xenopus embryos is sufficient to block erythropoiesis during normal development. Furthermore, introduction of exogenous GATA-1 in both MEL cells and Xenopus embryos and explants relieves the block to erythroid differentiation imposed by PU.1. Our results indicate that the stoichiometry of directly interacting but opposing transcription factors may be a crucial determinant governing processes of normal differentiation and malignant transformation.

摘要

恶性转化通常会抑制终末细胞分化,但其具体机制尚不清楚。PU.1是一种造血特异性Ets家族转录因子,是某些淋巴和髓系谱系发育所必需的。PU.1也可作为一种癌蛋白,因为前病毒插入或转基因激活其在红系前体细胞中的表达会导致小鼠患红白血病。恢复小鼠红白血病(MEL)细胞的终末分化需要PU.1水平下降,这表明PU.1可阻断红系分化。在此,我们研究PU.1干扰红系分化的机制。我们发现PU.1直接与GATA-1相互作用,GATA-1是红系分化所需的锌指转录因子。PU.1与GATA-1之间的相互作用需要两种蛋白质中完整的DNA结合结构域。PU.1抑制GATA-1介导的转录激活。PU.1的DNA结合结构域和反式激活结构域对于抑制都是必需的,并且这两个结构域对于阻断MEL细胞的终末分化也是必需的。我们还表明,在非洲爪蟾胚胎中异位表达PU.1足以在正常发育过程中阻断红细胞生成。此外,在MEL细胞、非洲爪蟾胚胎和外植体中引入外源性GATA-1可缓解PU.1对红系分化的阻断。我们的结果表明,直接相互作用但作用相反的转录因子的化学计量可能是决定正常分化和恶性转化过程的关键因素。

相似文献

引用本文的文献

本文引用的文献

6
The transcription factor Spi-1/PU.1 interacts with the potential splicing factor TLS.
J Biol Chem. 1998 Feb 27;273(9):4838-42. doi: 10.1074/jbc.273.9.4838.
7
Role of PU.1 in hematopoiesis.PU.1在造血过程中的作用。
Stem Cells. 1998;16(1):25-37. doi: 10.1002/stem.160025.
8
The lineage commitment of haemopoietic progenitor cells.
Curr Opin Genet Dev. 1997 Oct;7(5):609-13. doi: 10.1016/s0959-437x(97)80007-x.
10
Oncogenic transcription factors in the human acute leukemias.人类急性白血病中的致癌转录因子。
Science. 1997 Nov 7;278(5340):1059-64. doi: 10.1126/science.278.5340.1059.

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验